Setp14: A Protein Regulator of Cell Proliferation and Potential Drug/Biomarker

Target Name: SETP14

NCBI ID: G389168

SETP14

Other Name(s): SET pseudogene 14

Setp14: A Protein Regulator of Cell Proliferation and Potential Drug/Biomarker

Setp14, also known as SET pseudogene 14, is a gene that encodes a protein known as SET-14. Set-14 is a key regulator of cell proliferation and has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

The SET-14 gene was first identified in the late 1990s using techniques such as PCR and gene cloning. Since then, research has identified several different isoforms of the SET-14 gene, each with different levels of expression and function.

One of the most well-studied is the protein Set-14, which is a key regulator of cell proliferation and has been shown to play a role in a variety of processes, including cell growth, differentiation, and apoptosis. Set-14 is also involved in the development and maintenance of tissues, such as the brain and nervous system.

In addition to its role in cell proliferation, Set-14 has also been shown to play a role in the regulation of cell survival and the response to stress. Studies have shown that Set-14 can interact with a variety of protein partners, including the transcription factor p53, to promote the expression of genes that promote cell survival and the regulation of stress responses.

The discovery of Set-14 as a potential drug target or biomarker has implications for a variety of diseases. For example, Set-14 has been shown to be overexpressed in a variety of cancer types, including breast, ovarian, and prostate cancer. Therefore , targeting Set-14 with drugs or other therapeutic agents may be a promising strategy for the treatment of these diseases.

In addition to its potential as a drug target, Set-14 has also been identified as a potential biomarker for a variety of diseases. For example, studies have shown that the expression of Set-14 is associated with poor prognosis in a variety of cancer types, including breast, ovarian, and prostate cancer. Therefore, measuring the expression of Set-14 may be a useful diagnostic tool for these diseases and could also be a potential biomarker for the development of new treatments.

In conclusion, Setp14, or SET pseudogene 14, is a gene that encodes a protein known as SET-14. Set-14 is a key regulator of cell proliferation and has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. The discovery of Set-14 as a potential drug target or biomarker has implications for the treatment of these diseases and the development of new therapies. Further research is needed to fully understand the role of Set-14 in these processes and to develop effective treatments.

Protein Name: SET Pseudogene 14

The "SETP14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SETP14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets